278
Participants
Start Date
March 31, 2014
Primary Completion Date
August 17, 2016
Study Completion Date
October 31, 2016
Ciprofloxacin dispersion for inhalation
Placebo
Peoria
Phoenix
Downey
Los Angeles
Poway
Farmington
Washington D.C.
Celebration
Kissimmee
Miami
Sebring
Kailua
Chicago
Columbia
Royal Oak
Rochester
Lincoln
Cedar Knolls
New Hyde Park
New York
Syracuse
Charlotte
Huntersville
Oklahoma City
Anderson
Charleston
Columbia
Fort Worth
Tyler
Falls Church
Concord
Westmead
Brisbane
Cairns
South Brisbane
Daw Park
Footscray
Heidelberg
Adelaide
Calgary
Kelowna
Montreal
Borstel
Berlin
Donaustaff
Freiburg im Breisgau
Hanover
Immenstadt im Allgäu
Lübeck
Munich
Budapest
Debrecen
Miskolc
Szombathely
Dublin
Galway
Ashkelon
Haifa
Holon
Jerusalem
Kfar Saba
Rehovot
Tel Aviv
Pavia
Acquaviva delle Fonti
Bologna
Ferrara
Florence
Milan
Pisa
Cekule
Daugavpils
Liepāja
Riga
Bialystok
Chrzanów
Warsaw
Wroclaw
Bucharest
Constanța
Timișoara
Durban
Pietermaritzburg
Cape Town
eManzimtoti
Krugersdorp
Busan
Seoul
Palma de Mallorca
Barcelona
Girona
Madrid
Málaga
Kaohsiung City
Taichung
Taipei
Glasgow
Birmingham
Bradford
Dundee
Liverpool
Llandough
London
Manchester
Newcastle upon Tyne
Nottinghamshire
Stoke-on-Trent
Tyne and Wear
Wolverhampton
Lead Sponsor
Collaborators (1)
Grifols Therapeutics LLC
INDUSTRY
Aradigm Corporation
INDUSTRY